STOCK TITAN

Firefly Neuroscience (AIFF) shifts Gil Issachar to Head of AI, ends officer status

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Firefly Neuroscience, Inc. reports a change in the role and status of former Chief Technology Officer Gil Issachar. On June 18, 2026, Deel Innovation Ltd., which provides consulting services to Firefly, entered into an employment agreement with Issachar under which he now serves as Head of AI and Neuroscience for the company.

The new agreement supersedes all prior employment terms between Firefly and Issachar. Effective June 18, 2026, the board determined that Issachar is no longer classified as a Section 16 officer or executive officer of Firefly Neuroscience. The employment agreement is filed as Exhibit 10.1.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Role change effective date June 18, 2026 Effective date of Gil Issachar’s new position and status change
Section 16 officer regulatory
"Issachar is no longer classified as a Section 16 officer or executive officer of the Company."
A Section 16 officer is a corporate executive who, under U.S. securities law, must publicly report their purchases and sales of the company’s stock and is subject to rules that can force them to return short-term trading profits. Think of them as an insider required to keep a public trading log so investors can see when executives are buying or selling; that transparency helps investors assess management’s confidence and reduces the risk of undisclosed insider trading.
executive officer regulatory
"Issachar is no longer classified as a Section 16 officer or executive officer of the Company."
Employment Agreement financial
"entered into an employment agreement (the “Issachar Employment Agreement”) with Gil Issachar"
Emerging Growth Company regulatory
"Emerging Growth Company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0000803578 0000803578 2026-06-18 2026-06-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 18, 2026

 

FIREFLY NEUROSCIENCE, INC.
(Exact name of registrant as specified in its charter)

 

Delaware   001-41092   54-1167364
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

1100 Military Road, Kenmore, NY   14217
(Address of principal executive offices)   (Zip Code)

 

(888) 237-6412
(Registrant’s telephone number, including area code)

 

 
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   AIFF   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging Growth Company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On June 18, 2026, Deel Innovation Ltd. (“Deel”), which provides consulting services to Firefly Neuroscience, Inc., a Delaware corporation (the “Company”), entered into an employment agreement (the “Issachar Employment Agreement”) with Gil Issachar (“Issachar”), formerly the Chief Technology Officer of the Company, pursuant to which Issachar now serves as the Head of AI and Neuroscience of the Company. The Issachar Employment Agreement supersedes any prior terms and conditions of any employment agreement between the Company and Issachar. In connection with Issachar’s role change, the board of directors of the Company determined that effective June 18, 2026, Issachar is no longer classified as a Section 16 officer or executive officer of the Company.

 

The foregoing description of the Issachar Employment Agreement is qualified in its entirety by reference to the full text of the Addendum, which is filed as Exhibit 10.1 to this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
10.1   Employment Agreement between Deel Innovation Ltd. and Gil Issachar, dated June 18, 2026
104   Cover Page Interactive Data File (embedded with the Inline XBRL document).

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

 

Date: June 22, 2026

FIREFLY NEUROSCIENCE, INC.

   
  /s/ Greg Lipschitz
  Name: Greg Lipschitz
  Title: Chief Executive Officer

 

2

 

FAQ

What executive change did Firefly Neuroscience (AIFF) disclose on June 18, 2026?

Firefly Neuroscience disclosed that former Chief Technology Officer Gil Issachar assumed the role of Head of AI and Neuroscience. This change was implemented through a new employment agreement and reflects a shift in his responsibilities within the company’s technology and neuroscience efforts.

How did Firefly Neuroscience (AIFF) change Gil Issachar’s officer status?

Effective June 18, 2026, Firefly’s board determined that Gil Issachar is no longer a Section 16 officer or executive officer. This reclassification means he is no longer treated as one of the company’s senior reporting officers under applicable securities regulations.

Who employs Gil Issachar after the new arrangement with Firefly Neuroscience (AIFF)?

After the new arrangement, Gil Issachar is employed by Deel Innovation Ltd., which provides consulting services to Firefly Neuroscience. Deel entered into the employment agreement with Issachar, while he continues to serve as Head of AI and Neuroscience for Firefly.

What agreement governs Gil Issachar’s new role at Firefly Neuroscience (AIFF)?

Issachar’s new role is governed by an employment agreement between Deel Innovation Ltd. and Gil Issachar dated June 18, 2026. This agreement supersedes any prior employment terms between Firefly Neuroscience and Issachar, establishing the updated conditions of his service.

What exhibit in the Firefly Neuroscience (AIFF) 8-K relates to the employment change?

Exhibit 10.1 in the 8-K is the employment agreement between Deel Innovation Ltd. and Gil Issachar dated June 18, 2026. This exhibit contains the full contractual details underlying his new position as Head of AI and Neuroscience at Firefly.

What consulting role does Deel Innovation Ltd. have with Firefly Neuroscience (AIFF)?

Deel Innovation Ltd. provides consulting services to Firefly Neuroscience. Under the June 18, 2026 employment agreement with Gil Issachar, Deel employs him while he continues serving Firefly as Head of AI and Neuroscience, linking Deel’s consulting role to Firefly’s technology leadership.

Filing Exhibits & Attachments

4 documents